Side-by-side comparison of AI visibility scores, market position, and capabilities
San Antonio ecommerce search and merchandising platform founded 2007; raised $35M+; replaces platform-native search for retailers with large catalogs on Shopify, Magento, and WooCommerce.
Searchspring was founded in 2007 in San Antonio, Texas and raised over $35M to build a dedicated e-commerce search and merchandising platform for mid-market and enterprise online retailers. The company addresses a well-documented problem in e-commerce: the search and category navigation capabilities built into platforms like Shopify, Magento, and WooCommerce are insufficiently powerful for retailers with large, complex catalogs, leading to poor product discovery experiences and lost revenue from failed searches.\n\nSearchspring's platform replaces the native search and navigation of e-commerce platforms with a purpose-built search engine that delivers fast, relevant results, intelligent faceted filtering, and merchandiser-controlled result ranking. The merchandising tools allow non-technical retail teams to customize search results, pin specific products, create redirect rules for common queries, and run A/B tests on search and category page layouts without engineering involvement. Personalization features use browsing and purchase history to tailor search results and recommendations to individual shoppers.\n\nSearchspring serves mid-market retailers across apparel, sporting goods, home goods, and other product-rich categories where search relevance directly impacts conversion rates. The company competes against Klevu, Constructor, and Coveo in the e-commerce search market, differentiating through its strong merchandising control capabilities that are particularly valued by retailers with large buying and merchandising teams who rely on manual curation alongside algorithmic ranking.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.